Advertisement

Understanding the role of host response in influenza pneumonitis

  • Benjamin M. Tang
  • Carl G. Feng
  • Anthony S. McLeanEmail author
Understanding the Disease

Introduction

Most influenza-related deaths are caused by influenza pneumonitis, a serious complication of influenza virus infection characterised by uncontrolled lung inflammation, acute lung injury and respiratory failure. This serious complication has a high mortality risk (18–32%) [1]. The currently available antiviral therapy (e.g. neuraminidase inhibitor) has limited efficacy in reducing fatality caused by influenza pneumonitis.

Host factors, in additional to viral factors, are important in determining patient outcomes in influenza pneumonitis [2, 3]. A better understanding of the host factors associated with severe disease is therefore needed; it may help discover pathogenic pathways that determine disease progression and enable researchers identify new therapeutic targets. Here, we examine the immune cells underpinning the host response to influenza infection.

Innate immune cells

Alveolar macrophages in lungs are involved in the first line of defence. Following phagocytosis of...

Notes

Acknowledgements

We thank Andrew Sawyer for his graphic design of Fig. 1.

Compliance with ethical standards

Conflicts of interest

On behalf of all the authors the corresponding author states that there are no conflicts of interest.

References

  1. 1.
    Álvarez-Lerma F, Marín-Corral J, Vilà C et al (2017) Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit. J Hosp Infect 95:200–206.  https://doi.org/10.1016/j.jhin.2016.12.017 CrossRefGoogle Scholar
  2. 2.
    Herold S, Becker C, Ridge KM, Budinger GRS (2015) Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J 45:1463–1478.  https://doi.org/10.1183/09031936.00186214 CrossRefGoogle Scholar
  3. 3.
    Short KR, Kroeze EJBV, Fouchier RAM, Kuiken T (2014) Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis 14:57–69.  https://doi.org/10.1016/S1473-3099(13)70286-X CrossRefGoogle Scholar
  4. 4.
    Brandes M, Klauschen F, Kuchen S, Germain RN (2013) A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154:197–212.  https://doi.org/10.1016/j.cell.2013.06.013 CrossRefGoogle Scholar
  5. 5.
    Dunning J, Blankley S, Hoang LT et al (2018) Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil- associated patterns in severe influenza. Nat Immunol 19:625–635.  https://doi.org/10.1038/s41590-018-0111-5 CrossRefGoogle Scholar
  6. 6.
    Narasaraju T, Yang E, Samy RP et al (2011) Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 179:199–210CrossRefGoogle Scholar
  7. 7.
    Guan W, Yang Z, Wu NC et al (2018) Clinical correlations of transcriptional profile in patients infected with avian influenza H7N9 virus. J Infect Dis 218:1238.  https://doi.org/10.1093/infdis/jiy317 CrossRefGoogle Scholar
  8. 8.
    Venet F, Monneret G (2018) Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol 14:121–137.  https://doi.org/10.1038/nrneph.2017.165 CrossRefGoogle Scholar
  9. 9.
    Mina MJ, Klugman KP (2014) The role of influenza in the severity and transmission of respiratory bacterial disease. The Lancet Respir Med 2:750–763.  https://doi.org/10.1016/S2213-2600(14)70131-6 CrossRefGoogle Scholar
  10. 10.
    Schauwvlieghe AFAD, Rijnders BJA, Philips N et al (2018) Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. The Lancet Respir Med 6:782–792.  https://doi.org/10.1016/S2213-2600(18)30274-1 CrossRefGoogle Scholar
  11. 11.
    Sridhar S (2016) Heterosubtypic T-cell immunity to influenza in humans: challenges for universal T-cell influenza vaccines. Front Immunol 7:5086.  https://doi.org/10.3389/fimmu.2016.00195 CrossRefGoogle Scholar
  12. 12.
    Teluguakula N, Harshini A (2016) Neutrophils as possible therapeutic targets in severe influenza pneumonia. J Infect Pulm Dis 2:1Google Scholar
  13. 13.
    Venet F, Monneret G (2018) Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol 14:121–137.  https://doi.org/10.1038/nrneph.2017.165 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Intensive Care MedicineNepean HospitalKingswoodAustralia
  2. 2.Centre for Immunology and Allergy ResearchWestmead Institute for Medical ResearchWestmeadAustralia
  3. 3.Department of Infectious Diseases and Immunology, Sydney Medical SchoolUniversity of SydneySydneyAustralia

Personalised recommendations